XR Securities’s Biogen BIIB Stock Holding History

XR Securities’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,122	Closed	-$334K	–	381
2023 Q1	$312K	Sell	1,122 -3,241	-74%	-$897K	0.01%	313
2022 Q4	$1.21M	Buy	+4,363	New	+$1.23M	0.12%	145
2022 Q3	–	Sell	-2,393	Closed	-$508K	–	379
2022 Q2	$488K	Sell	2,393 -273	-10%	-$55.8K	0.16%	94
2022 Q1	$561K	Buy	2,666 +1,689	+173%	+$367K	0.1%	63
2021 Q4	$234K	Buy	+977	New	+$251K	0.02%	205
2021 Q2	–	Sell	-927	Closed	-$281K	–	433
2021 Q1	$259K	Buy	+927	New	+$250K	0.01%	170
2020 Q3	–	Sell	-3,562	Closed	-$953K	–	288
2020 Q2	$953K	Buy	+3,562	New	+$1.07M	0.11%	33
2020 Q1	–	Sell	-5,598	Closed	-$1.66M	–	214
2019 Q4	$1.66M	Sell	5,598 -2,449	-30%	-$680K	0.22%	26
2019 Q3	$1.87M	Buy	8,047 +3,772	+88%	+$878K	0.26%	19
2019 Q2	$1M	Buy	+4,275	New	+$987K	0.19%	32
2018 Q4	–	Sell	-1,420	Closed	-$453K	–	371
2018 Q3	$502K	Buy	+1,420	New	+$489K	0.13%	91

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

XR Securities's BIIB Position: Q2 2023 in Review

XR Securities sold out of Biogen (BIIB) in Q2 2023, closing a stake of 1,122 shares — an estimated $334K sold.

XR Securities first reported a position in BIIB in Q3 2018 and held it in 11 quarters. The position peaked at $1.87M in Q3 2019. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q2 2023.

XR Securities reported no remaining Biogen position as of Q2 2023 after selling out during the quarter.
XR Securities sold 1,122 Biogen shares in Q2 2023, an estimated $334K.
XR Securities first reported a position in Biogen in Q3 2018 and held it in 11 quarters.
XR Securities's Biogen position peaked at $1.87M in Q3 2019.
1,009 funds tracked by Wall St. Rank held Biogen as of Q2 2023.

Based on XR Securities's 13F filing for Q2 2023, filed 8 Aug 2023.